《大行報告》花旗上調創科(00669.HK)目標價至163元 去年業績勝預期
花旗發表的研究報告指,創科實業(00669.HK)今年以來訂單勢頭強勁,去年淨利按年升30%至8.01億美元,較市場及該行預期高7%及10%,花旗並將創科2021及2022年盈利預測升8%及6%,目標價由153元升至163元,評級「買入」。
該行指出去年公司收入按年增長28.5%,專業工具方面的增長則為25.8%,DIY/戶外業務收入升32%,而地板護理設備則升23.6%,估計經濟復甦及1.9萬億美元的經濟刺激措施應可抵銷原材料成本上升因素有餘,留意到今年以來訂單勢頭強勁,主要因為美國零售商及專業工具經銷商補貨,認為創科為中國工業股首選。
花旗認為利好因數包括歐美經濟復甦,料將刺激工程活動並帶動專業工具的需求,而美國1.9萬億美元的刺激措施亦料可帶動基建及消費,相信相關因素將抵銷原材料成本上升及居家抗疫需求減少的影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.